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Medical	  Device	  Software	  and	  Technology:	  
The	  Past,	  Present	  and	  Future	  
Dr	  Martin	  Mc	  Hugh	  
	  
Introduction	  
Early	  medical	  devices	  were	  crude	  and	  often	  dangerous.	  These	  devices	  had	  little	  complexity	  
and	   only	   performed	   basic	   tasks.	   However,	   with	   advances	   in	   technology	   also	   came	   an	  
increase	   in	   the	   complexity	   and	   functionality	   of	  medical	   devices.	  Medical	   devices	   became	  
more	  and	  more	  relied	  upon	  in	  every	  day	  healthcare.	  As	  with	  technology	  in	  other	  industries,	  
the	  medical	  device	  industry	  recognised	  the	  benefit	  of	  incorporating	  software	  into	  hardware	  
devices.	   Software	   was	   first	   used	   in	   medical	   devices	   in	   in	   the	   1980’s.	   At	   this	   time,	   the	  
software	   typically	  performed	   rudimentary	   functions	   such	  as	   turning	  a	  device	  on	  or	  off,	  or	  
displaying	  limited	  information	  such	  as	  a	  patient’s	  temperature.	  However,	  through	  advances	  
in	   technology,	   the	   role	   of	   software	   has	   expanded	   well	   beyond	   its	   humble	   beginnings.	   A	  
number	  of	  tasks	  traditionally	  performed	  manually	  by	  clinicians	  are	  now	  being	  performed	  by	  
automated	  software	  driven	  devices.	  Medical	  device	  manufacturers	  have	  embraced	  the	  use	  
of	  software	  in	  order	  to	  increase	  the	  level	  of	  functionality	  of	  their	  devices	  without	  the	  need	  
for	  costly	  mechanical	  additions.	  Using	  software	  to	  replace	  mechanical	  components	  can	  also	  
result	  in	  smaller,	  more	  portable	  medical	  devices.	  It	  is	  estimated	  that	  the	  amount	  of	  software	  
in	  medical	  devices	  doubles	  approximately	  every	  24	  months	  (1).	  	  
As	   the	   amount	   of	   software	   used	   in	   medical	   devices	   is	   increasing,	   so	   too	   is	   the	   level	   of	  
scrutiny	   which	   regulatory	   bodies	   are	   placing	   upon	   these	   devices.	   	   Traditional	   medical	  
devices	  consisted	  of	  hardware	  components	  which	  could	  easily	  be	  examined	  to	  determine	  if	  
a	  defect	  was	  present.	  However,	  with	  software	  driven	  medical	  devices	  it	  can	  be	  very	  difficult	  
to	  identify	  defects.	  To	  overcome	  this	  challenge,	  regulatory	  bodies	  place	  restrictions	  on	  the	  
processes	  that	  are	  followed	  when	  developing	  software	  for	  use	   in	  healthcare.	  Traditionally,	  
these	  restrictions	  only	  applied	  to	  a	  device	  manufacturer,	  as	  a	  medical	  device	  was	  seen	  as	  a	  
standalone	   entity	   however,	   this	   has	   now	   changed.	   Recent	   technological	   changes	   have	  
resulted	   in	   the	   ability	   to	   connect	  medical	   devices	   to	   existing	   network	   infrastructure.	   This	  
connectivity	  allows	  for	  the	  greater	  exchange	  of	  information	  and	  increases	  the	  availability	  of	  
information	  produced	  from	  a	  medical	  device.	  However,	  this	  has	  created	  the	  possibility	  that	  
devices	  sharing	  a	  network,	  which	  consists	  of	  a	  medical	  device,	  could	  have	  an	  impact	  on	  the	  
safe	  and	  reliable	  performance	  of	  that	  medical	  device.	  While	  manufacturers	  and	  distributors	  
are	   responsible	   for	   individual	   devices,	   Healthcare	   Delivery	   Organisations	   (HDO)	   are	  
responsible	  for	  ensuring	  that	  medical	  devices	  connected	  to	  a	  network	  perform	  as	  intended.	  
It	  has	  been	  shown	  that	  this	  responsibly	  typically	  falls	  upon	  clinical	  engineers	  and	  physicists	  
within	  HDOs.	  	  
The	   use	   of	   mobile	   devices	   is	   also	   on	   the	   rise	   in	   healthcare.	   These	   mobile	   devices	   offer	  
clinician	  access	  to	  a	  vast	  amount	  of	  information	  which	  can	  be	  used	  to	  help	  better	  diagnose	  
and	  treat	  patients.	  Nonetheless,	  a	  large	  amount	  of	  uncertainty	  remains	  with	  regards	  to	  the	  
regulation	  of	  these	  mobile	  devices	  for	  use	  in	  a	  healthcare	  environment.	  
The	  Past	  
In	  the	  US,	  the	  Food	  and	  Drug	  Administration	  (FDA)	  regulates	  medical	  devices.	  The	  FDA	  in	  its	  
current	   form	  originated	   in	  1930.	   In	  1938,	   the	  US	  Congress	  passed	  the	  Federal	  Food,	  Drug,	  
and	  Cosmetic	  Act	  (FFDCA).	  	  This	  act	  gave	  authority	  to	  the	  FDA	  to	  oversee	  the	  safety	  of	  food	  
drugs	  and	  cosmetics.	  In	  1976,	  the	  FFDCA	  was	  amended	  to	  include	  medical	  devices.	  The	  key	  
element	  of	   this	  amendment	  was	  that	  medical	  devices	  must	  be	  classified	   into	  one	  of	   three	  
categories	  i.e.	  Class	  I	  low	  risk,	  Class	  II	  medium	  risk	  and	  Class	  III	  High	  risk.	  Any	  medical	  device	  
that	  was	  marketed	   for	  use	  prior	   to	   this	   amendment	  became	  known	  as	   a	  pre-­‐amendment	  
device	  and	  as	  such,	  automatically	   received	  a	  Class	   III	   classification	  until	   reclassified	  by	   the	  
FDA.	  As	  discussed,	  software	  was	  first	  used	  in	  healthcare	  during	  the	  1980’s.	  Consequently,	  in	  
1981	  the	  FDA	  began	  to	  investigate	  the	  role	  of	  software	  in	  healthcare.	  In	  1987	  they	  published	  
their	  Draft	  Software	  Policy,	  as	  they	  recognised	  that	  software	  used	  in	  healthcare	  could	  meet	  
the	  definition	  of	  being	  a	  medical	  device.	  However,	  as	  the	  level	  of	  software	  based	  products	  
grew	   beyond	   the	   FDA’s	   expectations,	   they	   determined	   that	   it	  was	   impractical	   to	   adopt	   a	  
single	   software	  policy.	  As	   a	   result,	   the	  Daft	   Software	  Policy	  was	  never	  officially	   published	  
and	  was	  withdrawn	   in	   January	  2005.	  Currently,	   the	  FDA	  does	  not	  specifically	   regulate	  any	  
form	   of	   software	   used	   in	   healthcare	   and	   instead	   regulates	   “any	   instrument,	   apparatus,	  
implement,	   machine,	   contrivance,	   implant,	   in	   vitro	   reagent,	   or	   other	   similar	   or	   related	  
article,	  including	  a	  component	  part,	  or	  accessory”	  (2).	  
In	  November	  1997,	  the	  FDA	  signed	  into	  law	  the	  Modernisation	  act,	  known	  as	  the	  Food	  and	  
Drug	   Administration	   Modernization	   Act	   (FDAMA).	   A	   key	   element	   of	   FDAMA	   is	   the	  
advocating	  of	  the	  use	  of	  standards	  in	  the	  design	  review	  process.	  To	  support	  the	  FDAMA,	  the	  
FDA	   published	   in	   the	   Federal	   Register,	   a	   list	   of	   standards	   to	   which	   medical	   device	  
manufacturers	  could	  declare	  conformity.	  A	  key	  objective	  of	  the	  FDAMA	  was	  to	  reduce	  the	  
burden	   on	   both	   the	   FDA	   and	   medical	   device	   manufacturers	   by	   reducing	   the	   regulatory	  
obstacle	  to	  entry	  to	  international	  and	  domestic	  medical	  device	  markets.	  When	  the	  FDAMA	  
was	   signed	   into	   law,	   the	   Centre	   for	   Devices	   and	   Radiological	   Health	   (CDRH)	   established	  
Standards	  Technology	  Groups	  (STG),	  one	  of	  which	  had	  a	  specific	  focus	  on	  software.	  A	  STG	  is	  
responsible	  for	  software	  categorised	  as	  follows:	  
• General	  process	  standards,	  which	  are	  technology	  independent;	  
• General	  process	  standards,	  which	  are	  technology	  dependent;	  
• Specific	  process	  implementations.	  
A	   number	   of	   standards	   are	   included	   on	   the	   federal	   register	   list	   of	   standards,	   of	   most	  
significance	   with	   regards	   to	   medical	   device	   software	   development	   is	   IEC	   62304:2006	  
Medical	   Device	   –	   Software	   Life	   Cycle	   Processes.	   Also	   of	   significance	   to	   medical	   device	  
software	  and	  all	   types	  of	  medical	  device	   is	   ISO	  14971	  Application	  of	  Risk	  Management	   to	  
Medical	  Devices.	  All	  medical	  devices	  marketed	   for	  use	  within	   the	  US,	   regardless	  of	  device	  
safety	   classification,	  must	  provide	  evidence	  of	  adoption	  of	  a	  Quality	  Management	  System	  
(QMS),	  such	  as	  in	  accordance	  with	  21	  CFR	  820	  Quality	  Systems	  Regulations	  (QSR)	  (3)	  and	  the	  
FDA	  Design	  Control	  Guidance	  for	  Medical	  Device	  Manufacturers	  (4).	  Of	  note	  within	  the	  QSR	  
is	  Subpart	  C	  –	  Design	  Controls,	  which	  provides	   information	  as	  to	  which	  processes	  must	  be	  
adhered	  to	  when	  developing	  regulatory	  compliant	  software.	  These	  include:	  
• Design	  &	  Development	  Planning	  (Specifications);	  
• Design	  Output	  (Coding);	  
• Design	  Review;	  
• Design	  Verification	  (Was	  the	  Product	  Built	  Right);	  
• Design	  Validation	  (Was	  the	  Right	  Product	  Built).	  
	  
The	  primary	  objective	  of	  the	  QSR	  is	  to	  ensure	  the	  safe	  and	  reliable	  performance	  of	  a	  medical	  
device.	  A	  device	  is	  deemed	  safe	  if	  it	  does	  not	  cause	  harm	  to	  a	  patient,	  clinician	  or	  third	  party	  
and	  it	  is	  deemed	  reliable	  if	  it	  performs	  the	  desired	  function	  each	  and	  every	  time	  it	  is	  used.	  	  
In	  Europe,	  all	  medical	  devices	  marketed	  for	  use	  must	  conform	  to	  the	  regulations	  defined	  by	  
the	  European	  Council.	   	  Medical	   devices	   intended	   for	  use	  within	   the	  European	  Union	   (EU)	  
must	   have	   a	   CE	   conformance	   mark	   (5).	   To	   achieve	   this	   conformance	   mark,	   audits	   are	  
performed	  on	  these	  devices	  to	  ensure	  their	  safety	  and	  reliability	  by	  notified	  bodies	  within	  
each	   country.	  Within	   the	   Republic	   of	   Ireland,	   the	  National	   Standards	  Authority	   of	   Ireland	  
(NSAI)	   is	   one	   authority	   responsible	   for	   ensuring	   conformity	   before	   awarding	   a	   CE	   mark.	  
These	  devices	   typically	   needed	   to	   satisfy	   standards	  which	   include:	   EN	   ISO	  13485:2003	   (6)	  
medical	   device	   quality	   management	   standard,	   EN	   ISO	   14971:2009	   (7)	   and	   the	   medical	  
device	  product	  level	  standard	  IEC	  60601-­‐1	  (8,	  9).	  A	  key	  element	  of	  this	  process	  of	  achieving	  
conformance	  differs	  to	  that	  in	  the	  US,	  as	  there	  is	  no	  single	  authority	  responsible	  for	  ensuring	  
conformance.	   Once	   a	   medical	   device	   manufacturer	   has	   received	   the	   CE	   mark	   in	   one	   EU	  
member	  state,	  then	  they	  are	  free	  to	  market	  their	  medical	  device	  in	  any	  EU	  member	  state.	  
The	  Present	  
In	  2000,	  a	  report	  titled	  “To	  Err	  is	  Human”,	  identified	  that	  each	  year	  over	  98,000	  people	  die	  
in	   hospitals	   due	   to	   preventable	   causes.	   An	   example	   of	   one	   such	   failure	   is	   the	   Therac-­‐25.	  
Therac-­‐25	  used	  software	  to	  control	  when	  a	  radiation	  beam	  spreader	  plate	  should	  move	  into	  
place.	  A	  failure	  in	  this	  software	  resulted	  in	  the	  spreader	  plate	  not	  moving	  into	  place	  when	  
required,	  resulting	  in	  4	  patients	  dying	  and	  2	  being	  left	  permanently	  disfigured.	  A	  subsequent	  
report	  following	  these	  incidents	  identified	  that	  the	  software	  failed	  as	  a	  result	  of	  using	  legacy	  
software	  and	  a	  single	  developer.	   In	  another	  case,	  a	  Panamanian	  Teletherapy	  device	   failed	  
due	  to	  faulty	  software	  resulting	  in	  the	  death	  of	  21	  patients.	  It	  is	  reported	  that	  software	  was	  
cited	   as	   being	   the	  most	   common	   cause	   for	   a	  medical	   device	   recalls	   (10)	   with	   24%	   of	   all	  
medical	  devices	  recalled	  by	  the	  FDA	  in	  2011	  being	  as	  a	  result	  of	  software	  failures	  (11).	  
Software	  as	  a	  Medical	  Device	  
In	  2007,	  the	  European	  Council	  published	  the	  most	  recent	  amendment	  to	  the	  Medical	  Device	  
Directive	  (MDD)	  known	  as	  2007/47/EC	  (12).	  The	  original	  MDD,	  known	  as	  EC	  93/42/EEC	  (13)	  
was	  first	  published	  in	  1993	  and	  provided	  a	  definition	  as	  to	  what	  constitute	  a	  medical	  device	  
for	   use	   in	   the	   European	  Union.	  A	  number	  of	   changes	  were	   included	   as	   part	   of	   this	   latest	  
amendment,	  but	  perhaps	  the	  most	  significant	  change	  was	  the	  inclusion	  of	  software	  into	  the	  
definition	  of	  being	  a	  medical	  device.	  While	  the	  use	  of	  software	  in	  healthcare	  was	  recognised	  
prior	   to	   this,	   it	   was	   seen	   as	   a	   constituent	   component	   of	   a	   hardware	   medical	   device.	   To	  
provide	  further	  clarity	  as	  to	  what	  this	  change	  means,	  the	  amendment	  goes	  on	  to	  state	  that	  
“standalone	  software	  is	  considered	  to	  be	  an	  active	  medical	  device”.	  However,	  this	  wording	  
only	  served	  to	  cause	  more	  confusion	  amongst	  medical	  device	  manufacturers.	   In	  2012,	  the	  
European	   Council	   published	   MEDDEV	   2.1/6	   (14)	   to	   provide	   clear	   guidelines	   as	   to	   what	  
software	  could	  be	  considered	  as	  standalone	  software.	  This	  guidance	  document,	  as	  with	  the	  
FDA	   approach	   to	   software,	   confirmed	   that	   the	   intended	   use	   of	   the	   software	   is	   the	  
determining	   factor	   as	   to	   whether	   or	   not	   it	   was	   considered	   standalone	   software	   and	  
consequently	  be	  subject	  to	  regulatory	  scrutiny.	  
There	  are	  four	  different	  types	  of	  software	  used	  in	  healthcare	  which	  are	  subject	  to	  regulatory	  
scrutiny:	  
• Embedded	   software	   in	   a	  medical	   device	   e.g.	   software	   used	   as	   part	   of	   an	   infusion	  
pump;	  
• Standalone	   software	   as	   a	   medical	   device	   e.g.	   software	   running	   on	   a	   personal	  
computer	  which	  calculates	  chemotherapy	  dosages	  ;	  
• Hospital	  Information	  Technology	  e.g.	  electronic	  health	  records;	  
• Mobile	  Device	  Software	  e.g.	  smartphone	  and	  tablet	  apps.	  
FDA	  Medical	  Device	  Data	  Systems	  Rule	  
Prior	   to	  April	   16th	   2011,	   devices	   that	   now	  meet	   the	   current	   definition	  of	   being	   a	  Medical	  
Device	  Data	  System	  (MDDS)	  were	  classified	  as	  either	  a	  Class	  III	  device	  (potentially	  high	  risk),	  
or	   assumed	   the	   safety	   classification	   of	   the	   parent	   medical	   device	   to	   which	   they	   were	  
connected.	   However,	   the	   FDA	   had	   been	   operating	   under	   their	   discretionary	   enforcement	  
policy	  and	  therefore	  was	  not	  enforcing	  the	  Class	  III	  requirements	  on	  all	  MDDS.	  	  On	  April	  16th	  
2011,	   a	   FDA	   rule	   became	   effective	   which	   classified	   a	   MDDS	   device	   as	   a	   Class	   I,	   510	   (k)	  
exempt	   -­‐	  medical	   device	   (15).	   This	   ruling	   came	   three	   years	   after	   the	  proposed	   ruling	  was	  
issued	  on	  February	  8th	  2008.	  This	  final	  classification	  modifies	  FDA	  21	  C.F.R	  §	  880.6310	  (15)	  
and	  describes	  a	  MDDS	  as	  being:	  
	  “software,	   electronic,	   or	   electrical	   hardware	   such	   as	   a	   physical	  
communications	   medium	   (including	   wireless	   hardware),	   modems,	   interfaces	  
and	  communications	  protocol”	  	  
The	  FDA	  provided	  the	  following	  definition	  of	  what	  constitutes	  a	  MDDS:	  
“A	  device	  that	  is	  intended	  to	  provide	  one	  or	  more	  of	  the	  following	  uses,	  without	  
controlling	   or	   altering	   the	   functions	   or	   parameters	   of	   any	   connected	  medical	  
devices:	  
(i)	  The	  electronic	  transfer	  of	  medical	  device	  data;	  
(ii)	  The	  electronic	  storage	  of	  medical	  device	  data;	  
(iii)	   The	   electronic	   conversion	   of	   medical	   device	   data	   from	   one	   format	   to	  
another	  format	  in	  accordance	  with	  a	  pre-­‐set	  specification;	  or	  
(iv)The	  electronic	  display	  of	  medical	  device	  data.”	  
	  
There	  is	  however,	  an	  exception	  to	  this	  rule.	  If	  software	  exclusively	  performs	  one	  or	  more	  of	  
the	  functions	  outlined	  in	  the	  definition	  of	  a	  MDDS	  and	  is	  used	  for	  active	  patient	  monitoring,	  
then	   it	   cannot	   be	   considered	   a	   MDDS	   and	   must	   be	   considered	   an	   accessory	   or	   medical	  
device	   in	   its	   own	   right.	   This	   ruling	   created	   a	   level	   of	   ambiguity	   amongst	   medical	   device	  
software	   development	   organisations.	   Electronic	   Health	   Record	   (EHR)	   and	   Computerised	  
Physician	  Order	  Entry	  (CPOE)	  systems	  appear	  to	  meet	  the	  definition	  of	  being	  a	  MDDS,	  but	  
are	   explicitly	   outside	  of	   the	  definition	  of	   being	   a	  MDDS.	   The	   reason	   cited	   for	   this,	   is	   that	  
these	  systems	  possess	  the	  ability	  to	  order	  tests	  for	  patients	  automatically,	  thus	  generating	  
clinical	  data	  which	  is	  beyond	  the	  scope	  of	  a	  MDDS.	  
The	  Future	  
Mobile	  Health	  
The	   term	  Mobile	   Health	   or	   mHealth	   refers	   to	   the	   use	   of	   mobile	   devices	   to	   support	   the	  
practice	  of	  medicine.	  mHealth	  is	  most	  commonly	  seen	  in	  smartphones	  and	  tablets.	  Since	  the	  
inception	  of	   these	  devices,	   there	  have	  been	  apps	  designed	   for	  use	   in	  healthcare.	  Most	  of	  
these	  apps	  met	   the	  definitions	  of	  being	  medical	  devices	  and	   should	  have	  been	   subject	   to	  
regulatory	   scrutiny.	   However,	   the	   developers	   of	   these	   apps	   were	   avoiding	   regulatory	  
scrutiny	  by	  stating	  that	  the	  software	  they	  had	  developed	  was	  for	  lifestyle	  purposes	  and	  was	  
not	   intended	   for	   use	   in	   direct	   patient	   care.	   In	   2013,	   the	   FDA	   released	   its	  Mobile	  Medical	  
Applications	  Guidance	   for	   Industry	   and	   Food	   and	  Drug	  Administration	   (15).	   This	   guidance	  
document	  brought	  clarity	  to	  medical	  device	  application	  (app)	  developers.	  Initially,	  confusion	  
arose	  as	  to	  whether	  platforms	  on	  which	  these	  apps	  operate	  would	  be	  subject	  to	  regulatory	  
scrutiny,	   for	   example,	   would	   the	   latest	   version	   of	   Android	   need	   to	   be	   approved	   by	  
regulatory	  bodies	  before	  a	  medical	  app	  which	  runs	  on	  Android	  could	  be	  approved	  for	  use.	  
Fortunately,	   regulatory	   bodies	   have	   decided	   that	   once	   the	   app	   is	   fully	   validated	   in	  
accordance	   with	   quality	   management	   regulations,	   such	   as	   ISO	   13485	   or	   the	   FDA	   Quality	  
System	   Regulations	   (3).	   A	   recent	   survey	   in	   the	   UK	   identified	   the	   potential	   benefits	   to	   be	  
gained	   by	   adopting	   mHealth	   (16).	   While	   this	   research	   is	   still	   in	   its	   early	   stages,	   it	   was	  
revealed	  that	   if	  mHealth	  was	  used	  correctly	  there	  could	  be	  a	  20%	  reduction	   in	  emergency	  
admissions,	  14%	  reduction	  in	  bed	  days	  and	  a	  decrease	  of	  45%	  in	  mortality	  rates.	  
Clinical	  Decision	  Support	  Systems	  
The	   decision	   process	   in	   healthcare	   is	   essential.	   There	   are	   three	   decision	   processes	  which	  
must	  be	  followed	  in	  connection	  with	  patient	  care(17):	  
• Diagnostic	   Process	   –	   determining	   which	   questions	   should	   be	   asked	   or	   tests	   to	  
perform	  to	  establish	  a	  diagnosis;	  
• Diagnosis	  –	  determining	  the	  patients	  diagnosis	  based	  upon	  the	  diagnostic	  process;	  
• Management	  –	  determining	  the	  best	  course	  of	  treatment	  for	  the	  patient	  based	  upon	  
the	  diagnosis.	  
As	  each	  of	  these	  processes	  is	  supported	  by	  the	  preceding	  one,	  a	  failure	  in	  one	  will	  result	  in	  
an	  overall	  failure	  in	  the	  treatment	  process	  and	  could	  result	  in	  adverse	  effects	  being	  suffered	  
by	  the	  patient.	  As	  a	  result,	  medical	  device	  manufacturers	  have	  sought	  out	  a	  ways	  to	  support	  
these	  processes	  through	  the	  use	  of	  software.	  
Decision	   Support	   Systems	   (DSS)	   is	   a	   software	   application	   which	   provides	   a	   solution	   to	   a	  
decision	  maker	  by	  compiling	  useful	  information	  from	  a	  number	  of	  sources,	  such	  as	  raw	  data,	  
documents	   and	   personal	   experiences.	   DSS	   have	   gained	   acceptance	   in	   other	   industries	   to	  
assist	  in	  resolving	  structured	  and	  unstructured	  problems.	  
The	   healthcare	   industry	   has	   begun	   to	   embrace	   DSS,	   creating	   Clinical	   Decision	   Systems	  
(CDSS).	   CDSS	   are	   of	   particular	   use	   in	   the	   healthcare	   industry	   as	   they	   take	   into	   account	   a	  
number	   of	   variables	   and	   factors.	   These	   CDSS	   can	   provide	   clinicians	   with	   solutions	   based	  
upon	  extensive	  records.	  Should	  a	  clinician	  wish	  to	  form	  the	  same	  solution	  without	  a	  CDSS,	  
they	   would	   need	   to	   perform	   an	   exhaustive	   amount	   of	   research.	   This	   may	   be	   feasible	   in	  
isolated	   cases,	   however	   for	   routine	   cases,	   the	   costs	   of	   implementing	   the	   CDSS	  would	   be	  
exceeded	  by	  the	  ultimate	  benefits.	  An	  example	  of	  one	  such	  CDSS	  is	  an	  app	  developed	  by	  an	  
Irish	   software	   organisation	   known	   as	   OncoAssist.	   This	   app,	   intended	   to	   run	   on	   mobile	  
platforms,	   was	   developed	   in	   conjunction	   with	   oncologists	   to	   provide	   treatment	   dosages	  
based	  upon	  a	  large	  volumes	  of	  historical	  data.	  This	  app	  is	  one	  of	  the	  first	  mobile	  apps	  of	  its	  
kind	  to	  receive	  regulatory	  approval	  in	  Europe.	  	  
Medical	  IT	  Networks	  
Traditionally,	  when	  medical	  devices	  were	  connected	  to	  a	  network,	  the	  network	  would	  be	  an	  
isolated	  network	  consisting	  of	  proprietary	  devices,	   installed	  and	  supported	  by	  the	  medical	  
device	  vendor.	  This	  allowed	  the	  medical	  device	  vendor	  to	  have	  control	  over	  configuration,	  
such	   as	   IP	   addressing,	   which	   made	   support	   and	   service	   of	   the	   network	   easier.	  With	   the	  
medical	  device	  vendor	  providing	  the	  network,	  this	  relieved	  the	  hospital	  of	  the	  responsibility	  
of	  supporting	  life	  critical	  applications	  themselves.	  However,	  use	  of	  proprietary	  networks	  in	  
this	  way	  presented	  a	  number	  of	  disadvantages	  in	  that	  as	  medical	  devices	  increasingly	  were	  
designed	   to	   be	   incorporated	   into	   a	   network,	   the	   result	   was	   a	   proliferation	   of	   these	  
networks,	   resulting	   in	   the	   situation	   where	   large	   hospitals	   could	   have	   a	   large	   number	   of	  
isolated	   networks.	   The	  maintenance	   of	   a	   large	   number	   of	   private	   networks	   is	   impractical	  
and	   increasingly	  devices	  are	  being	  designed	   to	  be	   incorporated	   into	  a	  hospitals	  general	   IT	  
network.	   General	   hospital	   IT	   networks	   are	   highly	   flexible	   and	   highly	   configurable.	  
Incorporating	   a	  medical	   device	   into	   an	   IT	   network	   can	   introduce	   additional	   risks	   that	   are	  
specific	   to	   the	   that	   device,	   which	   may	   not	   have	   been	   considered	   during	   the	   design	   and	  
manufacture	  of	  the	  device	  (18).	  
In	  order	  to	  address	  these	  risks,	  IEC	  80001-­‐1:	  Application	  of	  risk	  management	  for	  IT-­‐networks	  
incorporating	   medical	   devices	   (19)	   was	   published	   in	   2010	   which	   outlines	   the	   roles,	  
responsibilities	   and	   activities	   that	   are	   required	   for	   the	   risk	   management	   of	   a	   medical	   IT	  
network.	   IEC	   80001-­‐1	   advocates	   a	   life	   cycle	   approach	   to	   risk	  management.	   The	   standard	  
looks	  at	  the	  medical	  IT	  network	  from	  the	  perspective	  of	  maintaining	  3	  key	  properties	  of	  the	  
network	   –	   Safety,	   Effectiveness	   and	   (Data	  &	   System)	   Security.	   Safety	   deals	  with	   ensuring	  
that	   the	   device	   does	   not	   cause	   harm	   to	   the	   patient,	   the	   user	   of	   the	   device	   or	   the	  
environment.	  Effectiveness	  is	  concerned	  with	  ensuring	  that	  the	  device	  continues	  to	  provide	  
the	   intended	   result	   for	   the	   patient	   and	   the	   Responsible	   Organization.	   A	   Responsible	  
Organisation	   is	   defined	   within	   the	   standard	   as	   an	   entity	   accountable	   for	   the	   use	   and	  
maintenance	   of	   a	   medical	   IT	   network.	   Data	   &	   System	   Security	   ensures	   that	   information	  
assets	   are	   reasonably	   protected	   from	   degradation	   of	   confidentiality,	   integrity	   and	  
availability.	   A	   medical	   IT	   network	   is	   defined	   within	   IEC	   80001-­‐1	   as	   “an	   IT	   network	   that	  
incorporates	  at	  least	  one	  medical	  device”.	  	  
Conclusions	  
Medical	  technology	  has	  changed	  dramatically	  over	  the	  past	  40	  years.	  The	  level	  of	  software	  
in	   medical	   devices	   has	   grown	   exponentially	   since	   its	   first	   inception.	   Software	   initially	  
performed	  very	  limited	  tasks	  as	  part	  of	  a	  hardware	  device,	  however,	  this	  has	  now	  evolved	  to	  
software	  potentially	  being	  considered	  a	  medical	  device	  in	  its	  own	  right.	  	  While	  the	  inclusion	  
of	   software	   has	   increased	   the	   capabilities	   of	   medical	   devices,	   the	   number	   of	   failures	   of	  
medical	  devices	  due	  to	  software	  faults	  has	  also	  increased	  and	  this	  has	  drawn	  extra	  attention	  
from	  regulatory	  bodies.	  	  
A	   traditional	   medical	   device	   consisted	   primarily	   of	   hardware	   with	   the	   possibility	   of	   a	  
software	   component.	   Due	   to	   advances	   in	   software	   technology,	   regulatory	   bodies	   have	  
extended	   their	   definition	   of	   a	   medical	   device	   and	   now	   a	   medical	   device	   can	   be	   solely	  
software	  with	  no	  hardware	  component.	  While	  this	  has	  created	  confusion	  amongst	  medical	  
device	   manufacturers	   as	   to	   whether	   or	   not	   software	   is	   or	   is	   not	   a	   medical	   device,	   they	  
simply	  need	   to	   refer	   to	   the	   intended	  use	  of	   the	   software	   and	   if	   this	  meets	   the	  definition	  
provided	  by	  regulatory	  bodies,	  then	  the	  software	  is	  defined	  as	  being	  a	  medical	  device.	  	  
The	   use	   of	  mobile	   apps	   are	   growing	   at	   a	   fast	   pace	  within	   healthcare	   as	   these	   apps	   offer	  
clinicians	  the	  ability	  to	  consult	  large	  amounts	  of	  historical	  data	  which	  assist	  them	  in	  making	  
more	  informed	  clinical	  decisions,	  for	  example	  CDSS.	  These	  assist	   in	  the	  three	  stages	  of	  the	  
diagnosis	   and	   treatment	   stage	   and	   will	   no	   doubt	   become	   common	   place	   in	   modern	  
healthcare.	  It	  can	  be	  seen	  that	  advances	  in	  medical	  technology	  have	  grown	  at	  a	  furious	  pace	  
of	   the	   past	   40	   years	   and	   through	   the	   further	   advancements	   including	  mobile	   technology,	  
this	  growth	  is	  expected	  to	  continue.	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